Scholar Rock Holding Corp (SRRK)
27.50
+0.12
(+0.44%)
USD |
NASDAQ |
Nov 14, 16:00
27.50
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock Cash and Short Term Investments (Quarterly): 190.49M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 190.49M |
| March 31, 2024 | 238.43M |
| December 31, 2023 | 279.94M |
| September 30, 2023 | 218.64M |
| June 30, 2023 | 248.73M |
| March 31, 2023 | 275.28M |
| December 31, 2022 | 315.36M |
| September 30, 2022 | 343.66M |
| June 30, 2022 | 370.69M |
| March 31, 2022 | 210.21M |
| December 31, 2021 | 252.99M |
| September 30, 2021 | 246.44M |
| June 30, 2021 | 282.22M |
| March 31, 2021 | 314.69M |
| Date | Value |
|---|---|
| December 31, 2020 | 341.03M |
| September 30, 2020 | 116.26M |
| June 30, 2020 | 141.18M |
| March 31, 2020 | 160.65M |
| December 31, 2019 | 157.45M |
| September 30, 2019 | 176.08M |
| June 30, 2019 | 185.13M |
| March 31, 2019 | 159.67M |
| December 31, 2018 | 175.64M |
| September 30, 2018 | 103.99M |
| June 30, 2018 | 115.06M |
| March 31, 2018 | 47.76M |
| December 31, 2017 | 57.96M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
116.26M
Minimum
Sep 2020
370.69M
Maximum
Jun 2022
247.60M
Average
248.73M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Cytokinetics Inc | 1.012B |
| Regeneron Pharmaceuticals Inc | 9.796B |
| Ocugen Inc | 38.70M |
| Mirum Pharmaceuticals Inc | 278.37M |
| NeuroBo Pharmaceuticals Inc | 21.67M |